An updated guideline from the American Academy of
Pediatrics offers pediatricians guidance in diagnosing, treating and preventing
bronchiolitis, a disorder commonly caused by viral infections of the lower
respiratory tract that is the most common cause of hospitalization among
infants under 1 year of age. The guideline, “Clinical Practice Guideline: The Diagnosis, Management, and Prevention of Bronchiolitis
,” is published in the
November 2014 Pediatrics (published online Oct. 27). It updates and revises a
previous guideline published in 2006. The new guideline, which applies to
children from 1 to 23 months of age, emphasizes that testing for specific
viruses is unnecessary because bronchiolitis may be caused by multiple viruses.
Because evidence shows bronchodilators are not effective in changing the course
of the illness, the new guideline no longer recommends a trial dose of a bronchodilator.
The guideline updates recommendations for use of palivizumab for prevention of
infections associated with respiratory syncytial virus (RSV), to align with an
AAP policy statement published in July 2014. The guideline, which is based on a
comprehensive evidence review, emphasizes that only supportive care such as
oxygen and hydration is strongly recommended in bronchiolitis.
American Academy of Pediatrics is an organization of 62,000 primary
cared pediatricians, pediatric medical subspecialists and pediatric
surgical specialists dedicated to the health, safety and well being of
infants, children,adolescents and young adults. For more information,